NovaBay Pharmaceuticals Inc (NBY) — Strategic Asset Allocation Index
NovaBay Pharmaceuticals Inc (NBY) has a Strategic Asset Allocation Index of 11.9% as of September 2025. Strategic assets (PP&E of $195.00K plus long-term investments of $-) total $195.00K, measured against net assets of $1.63 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check NBY financial resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
NovaBay Pharmaceuticals Inc Strategic Asset Allocation Index (2005–2023)
This chart shows how NovaBay Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 18 annual periods from 2005 to 2023. As of September 2025, the index stands at 11.9%, representing strategic assets of $195.00K against net assets of $1.63 Million USD. See NBY FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for NovaBay Pharmaceuticals Inc (2005–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for NovaBay Pharmaceuticals Inc from 2005 to 2023, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see NBY stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 41.7% | $1.38 Million | $1.38 Million | $- | $3.31 Million | ▲ +23.3 pp |
| 2022 | 18.5% | $1.95 Million | $1.95 Million | $- | $10.55 Million | ▲ +12.5 pp |
| 2021 | 5.9% | $604.00K | $604.00K | $- | $10.17 Million | ▲ +1.7 pp |
| 2020 | 4.2% | $520.00K | $520.00K | $- | $12.32 Million | ▼ -7.1 pp |
| 2019 | 11.3% | $110.00K | $110.00K | $- | $973.00K | ▲ +7.2 pp |
| 2018 | 4.1% | $201.00K | $201.00K | $- | $4.95 Million | ▼ -14.1 pp |
| 2017 | 18.2% | $471.00K | $471.00K | $- | $2.59 Million | ▲ +12.9 pp |
| 2016 | 5.2% | $371.00K | $371.00K | $- | $7.10 Million | ▼ -18.4 pp |
| 2014 | 23.6% | $436.00K | $436.00K | $- | $1.85 Million | ▲ +15.2 pp |
| 2013 | 8.4% | $718.00K | $718.00K | $- | $8.52 Million | ▲ +2.1 pp |
| 2012 | 6.3% | $891.00K | $891.00K | $- | $14.05 Million | ▼ -7.2 pp |
| 2011 | 13.6% | $1.27 Million | $1.27 Million | $- | $9.34 Million | ▼ -1.5 pp |
| 2010 | 15.1% | $1.59 Million | $1.59 Million | $- | $10.49 Million | ▲ +1.6 pp |
| 2009 | 13.6% | $1.81 Million | $1.81 Million | $- | $13.35 Million | ▼ -6.2 pp |
| 2008 | 19.8% | $1.46 Million | $1.46 Million | $- | $7.34 Million | ▲ +11.8 pp |
| 2007 | 8.0% | $1.15 Million | $1.15 Million | $- | $14.32 Million | ▼ -22.5 pp |
| 2006 | 30.6% | $554.00K | $554.00K | $- | $1.81 Million | ▲ +22.3 pp |
| 2005 | 8.2% | $267.00K | $267.00K | $- | $3.25 Million | — |